About
Photon Therapeutics is a UK-based medical technology company founded in 2010 and headquartered in London. The company specializes in ophthalmology, focusing on innovative treatments for corneal infections using ultraviolet (UV) light technology. Their flagship product, the PhotonUVC Vet, is a non-contact device that rapidly treats corneal infections in just five seconds. Initially aimed at the veterinary market, the company plans to expand its applications to human clinical use within the next few years. Co-founded by ophthalmic experts Dr. Sunil Shah and Dr. Simon Dean, Photon Therapeutics has received recognition in the ophthalmic community for its innovative approach, winning awards such as the ESCRS iNovation® Day and The Winning Pitch Challenge. The company is committed to ongoing clinical research and development, focusing on improving wound healing outcomes. With plans to serve both veterinary clinics and, eventually, optometry and ophthalmology clinics, Photon Therapeutics aims to enhance infection management in eye care while addressing the challenge of antibiotic resistance.
Technologies
Keywords
Company Information
-
Employees 6
-
Founded 2019
Location
34 Croydon Road, Caterham, England, United Kingdom, CR3 6PE